Claris Lifesciences has dipped nearly 8% to Rs 158 on back of heavy volumes on the Bombay Stock Exchange (BSE). The stock is turns ex-buyback of shares today.
The pharmaceutical company has fixed April 02 as the record date for purpose of determining entitlement and names of equity shareholders, to whom the letter of offer and tender form will be sent and who are eligible to participate in the buyback offer.
The company has proposed to buyback up to 9.25 million shares, representing 15%t of the paid up capital at Rs 250 per share aggregating to Rs 231.25 crore.
The buy back is proposed to be implemented by the company through tender offer process from equity shareholders on a proportionate basis, the company said in its filing.
At 1035 hours, around 236,000 shares already changed hands against an average 282,000 shares that were traded daily in past two weeks on the BSE. The stock opened at Rs 165 and touched a low of Rs 154 so far.
The pharmaceutical company has fixed April 02 as the record date for purpose of determining entitlement and names of equity shareholders, to whom the letter of offer and tender form will be sent and who are eligible to participate in the buyback offer.
The company has proposed to buyback up to 9.25 million shares, representing 15%t of the paid up capital at Rs 250 per share aggregating to Rs 231.25 crore.
The buy back is proposed to be implemented by the company through tender offer process from equity shareholders on a proportionate basis, the company said in its filing.
At 1035 hours, around 236,000 shares already changed hands against an average 282,000 shares that were traded daily in past two weeks on the BSE. The stock opened at Rs 165 and touched a low of Rs 154 so far.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%